http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107177001-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate | 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107177001-B |
| titleOfInvention | Egg yolk antibody for preventing and treating porcine epidemic diarrhea and preparation method thereof |
| abstract | The invention discloses a yolk antibody for resisting porcine epidemic diarrhea and a preparation method thereof, which comprises the steps of taking porcine epidemic diarrhea virus inactivated vaccine as immunogen, immunizing laying hens, harvesting yolk liquid and purifying the yolk antibody from the yolk liquid, wherein the porcine epidemic diarrhea virus strain is PEDV/CH/2014, and the preservation number is CGMCC No. 10111. The yolk antibody prepared by the invention has good properties, easy storage and high safety, and has good prevention and treatment effects: the neutralizing titer of the yolk antibody can reach 1: 128; the clinical prevention test can reduce the diarrhea incidence of the test pig by 20 percent, and the cure rate of the artificial infection reaches 100 percent. |
| priorityDate | 2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.